There is a controversy about the weighted risks and benefits of “statin” drugs, which are used primarily to reduce the blood levels of low-density lipoprotein (“bad cholesterol”). This article will discuss the statistical health risks of statins and … [Read more...]
Ketoacidosis
Diabetic ketoacidosis (DKA) is a dangerous medical condition that can affect anyone with diabetes, but is rare in type 2 diabetes. In DKA, acids build up in your blood. It can lead to diabetic coma and death. Invokana (canagliflozin) is in a class of … [Read more...]
Many People Giving Up on Statins because of Side Effects
A story earlier this month on NPR discussed the results of a study published in the Annals of Internal Medicine. The study looked at around 100,000 people who were taking cholesterol-lowering statins between 2000 and 2008, and showed that nearly 17 … [Read more...]
Diabetes Medications Linked to Pancreatitis
A study published in JAMA Internal Medicine has found that Januvia and Byetta, two popular GLP-1 therapies used for the treatment of diabetes, may greatly increase the risk of pancreatitis. The FDA flagged Byetta for pancreatitis in 2007 and … [Read more...]
FDA Severely Restricts Avandia
On September 23rd, the FDA announced severe restrictions to be placed on GlaxoSmithKline’s controversial diabetes drug Avandia. These restrictions make Avandia an option only for patients with Type 2 diabetes who cannot use other medications to … [Read more...]